A computational modeling framework for COVID-19 vaccination

COVID-19 疫苗接种的计算模型框架

基本信息

  • 批准号:
    10376956
  • 负责人:
  • 金额:
    $ 12.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global pandemic at present. Quantitative research is urgently needed to clarify the impacts of the current vaccination campaign on the pandemic evolution and economic growth, and to guide future policy development. The overall objective of this proposal is to establish a new computational modeling framework for an investigation of the COVID-19 vaccination campaign in the US, and to incorporate real data to assess the impacts of COVID-19 vaccination on public health and the economy. To achieve this objective, the team will pursue three specific aims: (1) Modeling the transmission and spread of COVID-19 under the impact of vaccination; (2) Modeling the economic impact of COVID-19 vaccination; (3) Conducting a case study for the Chattanooga region in the state of Tennessee. The proposed research is significant because it will incorporate detailed characteristics and potential limitations of the current vaccination campaign (such as the vaccine efficacy, phased allocation schemes, public resistance to vaccination, and vaccine breakthrough due to new variants of SARS- CoV-2) into a sophisticated modeling framework, which will enable us to make more accurate forecasts on the progression and long-term evolution of the pandemic. As such, the project is expected to advance the current understanding of COVID-19 transmission and to quantify the interaction between epidemic spreading, economic growth, and disease prevention and intervention under the impact of COVID-19 vaccination, all of which are important for the control and management of the pandemic. The approach is innovative in the development of a computational framework that integrates novel mechanistic and machine learning models and that connects the epidemic and economic aspects of COVID-19. The innovation of this project is also reflected by the integration of sophisticated computational modeling, rigorous mathematical analysis, intensive numerical simulation, and detailed data validation. The project represents an interdisciplinary collaboration among an applied and computational mathematician with long-term interest in infectious disease modeling (Wang), an epidemiologist with extensive working experiences at CDC and a current member of the regional COVID-19 task force (Heath), a business and management professor with a background in public heath (Mullen), and a statistician with expertise in machine learning and biomedical data analytics (Ma). The success of this project will not only build a solid knowledge base for the complex transmission dynamics of SARS-CoV-2 and the health and economic impacts of COVID-19 vaccination, but also provide important guidelines for the government agencies and public health administrations in pandemic management and policy development.
项目摘要/摘要 冠状病毒病2019年(新冠肺炎),由严重急性呼吸综合征冠状病毒2引起 非典冠状病毒(SARS-CoV-2)目前仍是一种全球大流行。迫切需要定量研究来澄清 当前疫苗接种运动对大流行演变和经济增长的影响,以及 引导未来政策发展。这项提议的总体目标是建立一个新的 美国新冠肺炎疫苗接种活动调查的计算模型框架, 并纳入真实数据,以评估新冠肺炎疫苗接种对公众健康和 经济舱。为了实现这一目标,团队将追求三个具体目标:(1)为 疫苗接种影响下新冠肺炎的传播与扩散;(2)经济建模 接种新冠肺炎疫苗的影响;(3)对查塔努加地区进行案例研究 田纳西州。拟议的研究具有重要意义,因为它将纳入详细的特征和 当前疫苗接种活动的潜在限制(如疫苗效力、分阶段分配 方案,公众对疫苗接种的抵抗力,以及由于SARS新变种而实现的疫苗突破- CoV-2)集成到一个复杂的建模框架中,这将使我们能够做出更准确的预测 关于大流行的进展和长期演变。因此,该项目有望取得进展 目前对新冠肺炎传播的认识与量化疫情之间的相互作用 新冠肺炎冲击下的传播、经济增长与疾病预防干预 疫苗接种,所有这些对控制和管理大流行都很重要。方法是 在开发计算框架方面具有创新性,该框架集成了新的机械和 机器学习模型,并将新冠肺炎的流行病和经济方面联系起来。这个 该项目的创新还体现在集成了复杂的计算建模, 严谨的数学分析、密集的数值模拟和详细的数据验证。该项目 表示应用数学家和计算数学家之间的跨学科协作 长期对传染病建模感兴趣(王),一位工作广泛的流行病学家 在疾病预防控制中心的经验和目前的地区新冠肺炎特别工作组(Heath)成员,一家企业和 管理学教授,有公共卫生背景(马伦),统计学家,有专业知识 机器学习和生物医学数据分析(MA)。该项目的成功不仅将建立一个 SARS-CoV-2复杂传播动力学与健康和健康的坚实知识基础 新冠肺炎疫苗接种的经济影响,也为政府提供了重要的指导方针 各机构和公共卫生行政部门在大流行管理和政策制定方面的合作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jin Wang其他文献

Jin Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jin Wang', 18)}}的其他基金

Mathematical Modeling and Scientific Computing for Infectious Disease Research
传染病研究的数学建模和科学计算
  • 批准号:
    10793008
  • 财政年份:
    2023
  • 资助金额:
    $ 12.26万
  • 项目类别:
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
开发一流的 RIPK1 降解剂以改善癌症免疫疗法
  • 批准号:
    10390589
  • 财政年份:
    2022
  • 资助金额:
    $ 12.26万
  • 项目类别:
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
开发一流的 RIPK1 降解剂以改善癌症免疫疗法
  • 批准号:
    10661495
  • 财政年份:
    2022
  • 资助金额:
    $ 12.26万
  • 项目类别:
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
开发一流的 RIPK1 降解剂以改善癌症免疫疗法
  • 批准号:
    10746264
  • 财政年份:
    2022
  • 资助金额:
    $ 12.26万
  • 项目类别:
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
开发用于治疗阿尔茨海默病的新型可溶性环氧化物水解酶抑制剂
  • 批准号:
    10503835
  • 财政年份:
    2020
  • 资助金额:
    $ 12.26万
  • 项目类别:
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
开发用于治疗阿尔茨海默病的新型可溶性环氧化物水解酶抑制剂
  • 批准号:
    10802956
  • 财政年份:
    2020
  • 资助金额:
    $ 12.26万
  • 项目类别:
Reversible Covalent BTK Degraders as the Next Generation Targeted Therapy to Treat B-cell Malignancies
可逆共价 BTK 降解剂作为治疗 B 细胞恶性肿瘤的下一代靶向疗法
  • 批准号:
    10737768
  • 财政年份:
    2020
  • 资助金额:
    $ 12.26万
  • 项目类别:
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
开发用于治疗阿尔茨海默病的新型可溶性环氧化物水解酶抑制剂
  • 批准号:
    10412114
  • 财政年份:
    2020
  • 资助金额:
    $ 12.26万
  • 项目类别:
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
开发用于治疗阿尔茨海默病的新型可溶性环氧化物水解酶抑制剂
  • 批准号:
    10663178
  • 财政年份:
    2020
  • 资助金额:
    $ 12.26万
  • 项目类别:
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
开发用于治疗阿尔茨海默病的新型可溶性环氧化物水解酶抑制剂
  • 批准号:
    10032662
  • 财政年份:
    2020
  • 资助金额:
    $ 12.26万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.26万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了